UAE Approves Sinopharm Vaccine as COVID-19 Booster
The United Arab Emirates has given emergency approval of Sinopharm’s protein-based COVID-19 vaccine for use as a booster dose against the pandemic, the country’s Health Ministry announced on Monday. The vaccine will be available to the public from January 2022. Production and distribution of the vaccine is a joint venture between the UAE’s Group 42 and China National Biotec Group (CNBG), a unit of China National Pharmaceutical Group (Sinopharm). The UAE has the highest rate of people fully vaccinated – almost 91% –in the MENA region. Almost 35% of the population has already received COVID-19 vaccine booster doses. But the UAE is reeling under the latest wave of infection. Over the past week, the number of confirmed cases rose 459% and the number of COVID-19 deaths rose 600%, compared to the previous week. The UAE now has the highest estimated effective reproduction rate (R) in the region, with each infected individual causing, on average, 2.36 new infections.
Give the gift of hope
We practice what we preach:
accurate, fearless journalism. But we can't do it alone.
- On the ground in Gaza, Syria, Israel, Egypt, Pakistan, and more
- Our program trained more than 100 journalists
- Calling out fake news and reporting real facts
- On the ground in Gaza, Syria, Israel, Egypt, Pakistan, and more
- Our program trained more than 100 journalists
- Calling out fake news and reporting real facts
Join us.
Support The Media Line. Save democracy.
